Jessica Steen, OD, FAAO

Dr. Steen teaches ocular pharmacology and serves as director of the glaucoma service at the NSU Eye Care Institute.


When good retinal surgery makes glaucoma go bad

Use of intravitreal biologics, steroids, and improvements to vitreoretinal surgical techniques have improved the prognosis of vitreoretinal conditions. Ocular hypertension, which may lead to secondary open-angle glaucoma, is a common complication both short- and long-term following intravitreal injection of anti-VEGF or steroid agent and PPV—especially when silicone oil is used as a tamponade agent. Understanding these potential risks is key to early detection, diagnosis, and management following vitreoretinal procedures.